Spots Global Cancer Trial Database for Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast
Official Title: Molecular Breast Imaging: Effect of Menstrual Cycle, Hormone Therapy, and Tamoxifen on Tc-99m Sestamibi Uptake in the Breast.
Study ID: NCT00943527
Conditions
Interventions
Study Description
Brief Summary: This study is to examine the effects of menstrual cycle, hormone therapy, and the use of tamoxifen on Tc-99m sestamibi uptake.
Detailed Description:
Eligibility
Minimum Age: 35 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
Mayo Clinic, Rochester, Minnesota, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
